Adjunctive Treatments for Inadequate Response to Daily Tadalafil
For men with inadequate response to daily tadalafil, the first-line adjunctive therapy is testosterone replacement if total testosterone is ≤3 ng/mL (300 ng/dL), as this combination significantly improves erectile function in hypogonadal men. 1
Algorithmic Approach to Adding Adjunctive Therapy
Step 1: Verify Proper Tadalafil Use
Before adding anything, confirm the patient is:
- Taking the medication consistently at the same time daily
- Understanding that sexual stimulation is required
- Not taking it with large meals (which can delay absorption)
- Has tried the therapy for at least 12 weeks (maximal benefits may not occur until this point) 2
Step 2: Check Testosterone Levels
Measure morning total testosterone (and bioavailable or free testosterone if total is borderline):
- If total testosterone ≤3 ng/mL (300 ng/dL): Add testosterone therapy 2
- This is the most evidence-based adjunctive treatment
- The 2025 EAU guidelines and 2018 AUA guidelines both recommend this combination 3, 1
- A landmark study showed significant benefit only when baseline testosterone was ≤3 ng/mL 2
- Testosterone alone does NOT work for ED; it must be combined with PDE5 inhibitors 1
Step 3: Consider Combination Therapies (if testosterone optimization fails or is not applicable)
Low-Intensity Shockwave Therapy (LI-SWT) + Daily Tadalafil:
- The 2025 EAU guidelines specifically note that LI-SWT combined with daily tadalafil shows enhanced results 3
- This is particularly beneficial in men with mild vasculogenic ED
- LI-SWT has shown benefit even in PDE5 inhibitor nonresponders 3
- One study demonstrated that adding L-arginine 2,500 mg daily to this combination further increased efficacy and duration of benefits 4
Vacuum Erection Device (VED):
- Can be added to daily tadalafil 3, 1
- Shows 90% initial efficacy but drops to 50-64% at 2 years 3
- Best suited for older patients with infrequent intercourse 3
- Contraindicated in men on anticoagulation or with bleeding disorders 1
Step 4: Escalate to More Invasive Options
If combination therapy with testosterone and/or LI-SWT fails:
Intraurethral (IU) Alprostadil:
- Requires in-office test dose before prescribing 1
- Success rates: 29.5-78.1% for achieving intercourse 1
- Can be used alongside daily tadalafil
Intracavernous Injection (ICI) Therapy:
- Requires in-office injection test 1
- Mean IIEF-EF improvement of 3.21 points vs placebo 3
- Only alprostadil is FDA-approved for ICI in the U.S. 1
- Can use combination formulations (papaverine + phentolamine + alprostadil)
Emerging Options (Limited Evidence):
- Botulinum toxin A showed promise in PDE5 inhibitor nonresponders, with up to 40% resuming satisfactory sexual activity 3
- Natural supplements: A 2024 study showed garlic (as H2S donor) with tadalafil improved IIEF-EF scores significantly 5, and another showed Icarifil® (L-Citrulline, L-Carnitine, herbal mixture) enhanced tadalafil efficacy 6
Step 5: Psychosocial Intervention
Add cognitive behavioral therapy or sexual skills training at any stage, as these complement medical ED treatment effectively 3
Critical Pitfalls to Avoid
- Don't add testosterone without checking levels first - benefit only occurs when baseline testosterone ≤3 ng/mL 2
- Don't expect immediate results - allow 12 weeks for full tadalafil effect before declaring treatment failure 2
- Don't prescribe testosterone alone for ED - it must be combined with PDE5 inhibitors 1
- Don't use VED in anticoagulated patients - risk of penile bruising and hematoma 1
- Don't skip the in-office test dose for IU alprostadil or ICI therapy - required for proper dosing and patient education 1
Contraindications to Remember
From the FDA label, tadalafil should not be combined with: